Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can virtual reality make stroke rehab more tolerable?

NCT ID NCT06053619

Symptom relief Sponsor: University Hospital, Limoges Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding immersive virtual reality (VR) to robotic walking rehabilitation is tolerable for people who cannot walk after a stroke. Thirty non-walking stroke patients will try both standard robotic rehab and VR-enhanced sessions. Researchers will measure motion sickness, motivation, and how much walking they actually do.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robotic-assisted walking rehabilitation with immersive virtual reality
What this could lead to
If successful, this could make walking rehab more engaging and tolerable for stroke patients, potentially improving recovery.
What could go wrong
This is a small, early-stage study (30 participants) focused on tolerance, not effectiveness. The VR may cause motion sickness or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hemiparesis following a first ischemic or hemorrhagic stroke; * subacute phase (15 days to 6 months); * Aged 35 to 75 years; * Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2); * Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital; * Having the cognitive abilities to understand and follow simple verbal instructions (MMSE \< 24 or BDAE \< 2) * Be able to give informed consent to participate in this study. Exclusion Criteria: * Have neurological and psychiatric conditions, other than stroke; * Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome). * Inability to evolve in a virtual environment (MSSQ-Short \> 26) * Patient with acute cardiovascular and respiratory disorders; * Patient who is subject to a legal protection measure or who is unable to give consent; * Person deprived of liberty * Person with high VR experience during the 5 years before stroke * pregnant woman, breastfeeding woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central nervous system diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

central nervous system disorder stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central nervous system diseases Stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Limoges

    RECRUITING

    Limoges, 87042, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.